• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用OKT3单克隆抗体与机械循环支持联合技术逆转急性暴发性淋巴细胞性心肌炎

Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support.

作者信息

Jett G K, Miller A, Savino D, Gonwa T

机构信息

Department of Cardiothoracic Surgery, Baylor University Medical Center, Dallas, Texas 75246.

出版信息

J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):733-8.

PMID:1498140
Abstract

Reported is a case of acute fulminant lymphocytic myocarditis with profound circulatory compromise that was successfully reversed by treatment with OKT3 monoclonal antibody. The patient was supported with biventricular assist devices while being treated with the monoclonal antibody. The patient had remarkable recovery of ventricular function, which allowed for the removal of the device after 8 days of support. This case shows the success of combined technologies of monoclonal antibody and mechanical circulatory support to treat a potentially fatal disease process.

摘要

报告了一例急性暴发性淋巴细胞性心肌炎伴严重循环功能障碍的病例,该病例通过使用OKT3单克隆抗体治疗成功逆转。患者在接受单克隆抗体治疗期间接受了双心室辅助装置支持。患者心室功能显著恢复,在支持治疗8天后得以撤除该装置。本病例显示了单克隆抗体与机械循环支持联合技术治疗潜在致命疾病过程的成功。

相似文献

1
Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support.采用OKT3单克隆抗体与机械循环支持联合技术逆转急性暴发性淋巴细胞性心肌炎
J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):733-8.
2
[A case of fulminant myocarditis treated by ABIOMED BVS 5000 biventricular support].
Kyobu Geka. 1998 Jun;51(6):451-6.
3
Mechanical circulatory support for the treatment of children with acute fulminant myocarditis.机械循环支持治疗儿童急性暴发性心肌炎
J Thorac Cardiovasc Surg. 2001 Sep;122(3):440-8. doi: 10.1067/mtc.2001.115243.
4
Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist.儿童和青少年急性暴发性心肌炎:机械循环辅助的作用
ASAIO J. 2006 Mar-Apr;52(2):211-4. doi: 10.1097/01.mat.0000178049.13589.31.
5
[Fulminant myocarditis successfully treated with a left ventricular assist device: a case report].[应用左心室辅助装置成功治疗暴发性心肌炎:一例报告]
J Cardiol. 2003 May;41(5):249-54.
6
Combined use of Impella left ventricular assist device and extracorporeal membrane oxygenation as a bridge to recovery in fulminant myocarditis.经皮左心室辅助装置 Impella 与体外膜肺氧合联合应用在暴发性心肌炎作为恢复的桥接治疗。
ASAIO J. 2012 May-Jun;58(3):285-7. doi: 10.1097/MAT.0b013e31824b1f70.
7
[A new percutan assist device for treatment of fulminant myocarditis].[一种用于治疗暴发性心肌炎的新型经皮辅助装置]
Ugeskr Laeger. 2007 Sep 24;169(39):3303-4.
8
Treatment and outcome of biopsy-proven fulminant myocarditis in adults.经活检证实的成人暴发性心肌炎的治疗与转归
Int J Cardiol. 2006 Jun 28;110(3):405-6. doi: 10.1016/j.ijcard.2005.07.082. Epub 2005 Nov 16.
9
Recovery of acute myocarditis with biventricular assist device in infant.婴儿急性心肌炎采用双心室辅助装置治疗后的恢复情况。
Int J Cardiol. 2005 Dec 7;105(3):344-5. doi: 10.1016/j.ijcard.2004.12.045.
10
Interventional and medical treatment of acute heart failure due to inflammation: four cases.炎症性急性心力衰竭的介入与药物治疗:4例报告
Herz. 2006 Nov;31(8):761-6. doi: 10.1007/s00059-006-2912-9.

引用本文的文献

1
Muronomab-CD3 for pediatric acute myocarditis.用于儿童急性心肌炎的鼠单克隆抗体-CD3
Pediatr Cardiol. 2007 Jan-Feb;28(1):21-6. doi: 10.1007/s00246-006-1322-3. Epub 2006 Dec 7.
2
Active lymphocytic myocarditis treated with murine OKT3 monoclonal antibody in a patient presenting with intractable ventricular tachycardia.在一名出现顽固性室性心动过速的患者中,用鼠源性OKT3单克隆抗体治疗活动性淋巴细胞性心肌炎。
Tex Heart Inst J. 2002;29(2):113-7.
3
Influence of myocarditis on left ventricular function.心肌炎对左心室功能的影响。
Trans Am Clin Climatol Assoc. 2000;111:20-35; discussion 35-7.
4
Recognition and optimum management of myocarditis.心肌炎的识别与最佳管理。
Drugs. 1996 Oct;52(4):515-25. doi: 10.2165/00003495-199652040-00005.